Sort
130,381 grants matching “hiv”
Center for Substance Use and AIDS Research on Latinos in the United States
$1,282,375Mario R. De La Rosa · Florida International University · P20 · FY2008 · MD
T Cell Immune Responses To HIV And Other Pathogens
$1,282,212Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Immune Reconstitution
$1,282,211Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
HIV Infection In Vivo And In Vitro
$1,282,210Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Natural History of HIV Infection in Injection Drug Users
$1,281,995Johns Hopkins University · R37 · FY2003 · DA
Molecular Analysis Of Retroviral Genes And Their Products
$1,281,990Klaus Strebel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
PS04-012, HIV PREVENTION PROJECTS
$1,281,925Sandra Klocke · Nebraska State Dept Of Health · U62 · FY2008 · PS
Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.
$1,281,839Francis W. Ruscetti · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Strategies for inducing bnAbs against QNES by infection with SHIVs
$1,281,787Shiu-Lok Hu · Rbhs-New Jersey Medical School · P01 · FY2013 · AI
CANCER CENTER SUPPORT GRANT
$1,281,474University Of California San Francisco · P30 · FY2000 · CA
The Manhattan HIV Brain Bank
$1,281,417Susan Morgello · Icahn School Of Medicine At Mount Sinai · U24 · FY2018 · MH
Enhancing B cell immunity against HIV-1 using novel vaccine delivery platforms
$1,281,293Michael W Cho · Iowa State University · U19 · FY2013 · AI
Phase 1 Clinical Trial Units for Therapeutics Against Infectious Diseases: Evaluation of Therapeutics for Resistant Bacterial Infections
$1,281,164Rob Caudle · Duke University · N01 · FY2017 · AI
CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)
$1,281,143Curt G Beckwith · Miriam Hospital · R01 · FY2012 · DA
AFE inhibitor combinations as topical microbicides against HIV-1
$1,281,125John P Moore · Weill Medical Coll Of Cornell Univ · U19 · FY2007 · AI
Project 2: Current Good Manufacture Practices (CGMP) Production of Nucleoside-Modified mRNAs Encoding HIV-1 Envelopes
$1,280,922Frederick Porter · Duke University · U19 · FY2021 · AI
Design of Drugs Against Cancer and Viral Diseases
$1,280,818Christopher Michejda · Basic Sciences · Z01 · FY2007 · CA
JOHNS HOPKINS ADULT AIDS CLINICAL TRIALS UNIT
$1,280,720Johns Hopkins University · U01 · FY2002 · AI
Cardiovascular Status of HAART-Exposed Infants/Children
$1,280,662University Of Rochester · R01 · FY2002 · HL
Chemically Modified Peptide Nucleic Acids
$1,280,656Daniel H Appella · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
TO REDUCE NEW HIV INFECTIONS; INCREASE ACCESS TO CARE & IMPROVE HEALTH FOR PEOPLE
$1,280,653Marlene McNeese-Ward · Houston Department/Health/Human Srvs · U65 · FY2011 · PS
Coordinating Center of Excellence in Social Promotion of Health Equity Research
$1,280,473Saundra H Glover · University Of South Carolina At Columbia · P20 · FY2014 · MD
Assessment of vaccine/microbicide combination efficacy in the macaque model
$1,280,247Cecilia C Cheng-Mayer · Aaron Diamond Aids Research Center · R01 · FY2009 · AI
Digital Phenotyping & Deep Learning: Substance Use Impact on PrEP Adherence among Black Sexual and Gender Minorities
$1,280,000Brenda Curtis · National Institute On Drug Abuse · ZIA · FY2023 · DA
Studies of Rare Cancers
$1,280,000Louise Brinton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA